Home |  Contact Us | Site Map

Investor Relations

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

Nov 5, 2009
BioCryst Receives First Peramivir Order From U.S. Government

Nov 4, 2009
BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in Japan

View all releases »

Investor Relations

Rob Bennett, Executive Director of Business Development & Investor Relations
919.859.7910
investorrelations@biocryst.com

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, New York 10038
Phone (718) 921-8247

Stock Information
NASDAQ : BCRX
$11.28   - 0.11
Nov 6, 2009
4:13 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.